BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 36090994)

  • 1. Identify metabolism-related genes IDO1, ALDH2, NCOA2, SLC7A5, SLC3A2, LDHB, and HPRT1 as potential prognostic markers and correlate with immune infiltrates in head and neck squamous cell carcinoma.
    Li C; Chen S; Jia W; Li W; Wei D; Cao S; Qian Y; Guan R; Liu H; Lei D
    Front Immunol; 2022; 13():955614. PubMed ID: 36090994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel metabolic-related gene signature for predicting clinical prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Cao Y; Dai Z; Xie G; Liu G; Guo L; Zhang J
    Exp Cell Res; 2023 Jul; 428(2):113628. PubMed ID: 37149080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLC3A2/CD98hc, autophagy and tumor radioresistance: a link confirmed.
    Digomann D; Linge A; Dubrovska A
    Autophagy; 2019 Oct; 15(10):1850-1851. PubMed ID: 31276435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Metabolism-Related Gene Prognostic Index Bridging Metabolic Signatures and Antitumor Immune Cycling in Head and Neck Squamous Cell Carcinoma.
    Du K; Zou J; Wang B; Liu C; Khan M; Xie T; Huang X; Shen P; Tian Y; Yuan Y
    Front Immunol; 2022; 13():857934. PubMed ID: 35844514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a metabolic reprogramming-related signature associated with prognosis and immune microenvironment of head and neck squamous cell carcinoma by in silico analysis.
    Qiang W; Dai Y; Xing X; Sun X
    Cancer Med; 2022 Aug; 11(16):3168-3181. PubMed ID: 35301800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SLA2 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment.
    Wu Z; You C; Zhu Z; Wu W; Cao J; Xie Q; Deng C; Huang X; Hu S
    Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):427-440. PubMed ID: 37688682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma.
    Takahashi H; Kawabata-Iwakawa R; Ida S; Mito I; Tada H; Chikamatsu K
    Sci Rep; 2021 Sep; 11(1):17789. PubMed ID: 34493792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-cell RNA sequencing reveals tumor immune microenvironment in human hypopharygeal squamous cell carcinoma and lymphatic metastasis.
    Li C; Guan R; Li W; Wei D; Cao S; Xu C; Chang F; Wang P; Chen L; Lei D
    Front Immunol; 2023; 14():1168191. PubMed ID: 37503341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma.
    Chen L; He X; Yi S; Liu G; Liu Y; Ling Y
    Biomed Res Int; 2021; 2021():8824195. PubMed ID: 33628816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]   [Full Text] [Related]  

  • 11. Exploring the Role and Prognostic Value of TMEM208 in Head and Neck Squamous Cell Carcinoma.
    Yang J; Song T
    Asian Pac J Cancer Prev; 2024 Mar; 25(3):909-919. PubMed ID: 38546073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma.
    Mito I; Takahashi H; Kawabata-Iwakawa R; Ida S; Tada H; Chikamatsu K
    Sci Rep; 2021 Aug; 11(1):16134. PubMed ID: 34373557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma Radiosensitivity.
    Digomann D; Kurth I; Tyutyunnykova A; Chen O; Löck S; Gorodetska I; Peitzsch C; Skvortsova II; Negro G; Aschenbrenner B; Eisenhofer G; Richter S; Heiden S; Porrmann J; Klink B; Schwager C; Dowle AA; Hein L; Kunz-Schughart LA; Abdollahi A; Lohaus F; Krause M; Baumann M; Linge A; Dubrovska A
    Clin Cancer Res; 2019 May; 25(10):3152-3163. PubMed ID: 30670494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-211-3p enhances induction chemotherapy insensitivity by upregulating CSF2/CCL20/TNF signaling in hypopharyngeal squamous cell carcinoma.
    Wang L; Wang R; Huang T; Yang Y; Feng L; Fang J
    Mol Biol Rep; 2022 Jul; 49(7):6103-6112. PubMed ID: 35397087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA-504 inhibits cancer cell proliferation via targeting CDK6 in hypopharyngeal squamous cell carcinoma.
    Kikkawa N; Kinoshita T; Nohata N; Hanazawa T; Yamamoto N; Fukumoto I; Chiyomaru T; Enokida H; Nakagawa M; Okamoto Y; Seki N
    Int J Oncol; 2014 Jun; 44(6):2085-92. PubMed ID: 24647829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLC13A4 Might Serve as a Prognostic Biomarker and be Correlated with Immune Infiltration into Head and Neck Squamous Cell Carcinoma.
    Yang ML; Zhang JH; Li S; Zhu R; Wang L
    Pathol Oncol Res; 2021; 27():1609967. PubMed ID: 34840533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell sequencing of head and neck carcinoma: Transcriptional landscape and prognostic model based on malignant epithelial cell features.
    Xiong M; Hu JJ; Yao ML; Song TT; Zhao L; Mou BQ; Qian YX; Zheng MJ; Dong YJ; Wang HY; Zou J; Yang H
    FASEB J; 2024 Jan; 38(1):e23354. PubMed ID: 38085162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of the prognosis and biological significance of ROR
    Zheng J; Tang H; Yang Y; Yang K
    Environ Toxicol; 2024 Feb; 39(2):487-508. PubMed ID: 37278231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma.
    Wang J; Tian Y; Zhu G; Li Z; Wu Z; Wei G; Zhuang L; Li Z; Chen X; Zhang X; Zheng J; Cai G
    Int Immunopharmacol; 2021 Aug; 97():107817. PubMed ID: 34091115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial-related genes markers that predict survival in patients with head and neck squamous cell carcinoma affect immunomodulation through hypoxia, glycolysis, and angiogenesis pathways.
    Li Z; Cai H; Zheng J; Chen X; Liu G; Lv Y; Ye H; Cai G
    Aging (Albany NY); 2023 Oct; 15(19):10347-10369. PubMed ID: 37796226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.